[HTML][HTML] Serological profiling of rabies antibodies by enzyme-linked immunosorbent assay and its comparative analysis with rapid fluorescent focus inhibition test in …

A Debnath, DC Pathak, N Ramamurthy, G Mohd… - Veterinary …, 2019 - ncbi.nlm.nih.gov
Aim: In this study, we have used enzyme-linked immunosorbent assay (ELISA) as an
alternative test to replace the cumbersome rapid fluorescent focus inhibition test (RFFIT) to …

Development of a relative potency test using ELISA for human rabies vaccines

Z Wang, Y Sun, X Wu, DS Carroll, W Lv, L You, Y Ji… - Biologicals, 2018 - Elsevier
The NIH potency test for human rabies vaccines has disadvantages for use, especially in
developing countries where rabies is endemic and prophylaxis needs ample, rapid, and …

A versatile in vitro ELISA test for quantification and quality testing of infectious, inactivated and formulated rabies virus used in veterinary monovalent or combination …

C Sigoillot-Claude, M Battaglio, M Fiorucci, D Gillet… - Vaccine, 2015 - Elsevier
Regulatory potency test for rabies vaccines requires mice vaccination followed by challenge
with a live virus via intracerebral route. An alternative in vitro test, consistent with the …

An ELISA-based antigenicity test of rabies recombinant glycoprotein cannot predict its protective potency in vivo

DV Volokhov, AM Fry, V Furtak, RM Jones… - Molecular and Cellular …, 2022 - Elsevier
The potency of human and veterinary rabies vaccines is measured based on the National
Institute of Health (NIH) potency test that is laborious, time-consuming, variable, and …

A novel in vitro ELISA for estimation of glycoprotein content in human rabies vaccines

SM Aavula, G Abhinay, SV Nimmagadda… - … of Immunoassay and …, 2017 - Taylor & Francis
In vitro methods for quantification of immunodominant glycoprotein in the rabies vaccine
formulations serve as good alternative to the cumbersome and variable mice potency assay …

Development of a time and cost benefit antibody binding test-based method for determination of rabies vaccine potency

V Asgary, N Mojtabavi, A Janani, T Mousavi… - Viral …, 2017 - liebertpub.com
This study is an improvement on the antibody binding test, known as ABT method, to
develop a simple and fast method in comparison with NIH for determination of rabies …

[PDF][PDF] FACTORES RELACIONADOS EN LA DETERMINACIÓN DE LA POTENCIA (DOSIS EFECTIVA 50) DE LAS VACUNAS ANTIRRÁBICAS EN CULTIVO …

REJ DE LA CRUZ, LUZC ARROYO - repositorio.upch.edu.pe
Introducción: La potencia de las vacunas antirrábicas para uso veterinario producidas por el
Instituto Nacional de Salud es determinada mediante el método in vivo NIH, este ensayo …

[PDF][PDF] СОВЕРШЕНСТВОВАНИЕ СПОСОБОВ ПОЛУЧЕНИЯ ВЫСОКООЧИЩЕННОГО АНТИГЕНА ВИРУСА БЕШЕНСТВА ДЛЯ ЭКСПРЕСС-ТЕСТ-СИСТЕМ НА …

АГ МУХАМЕДЖАНОВА - kazanveterinary.ru
Актуальность темы. На сегодняшний день бешенство–природно-очаговое особо
опасное смертельное инфекционное заболевание, вызываемое вирусом бешенства …

Serological profiling of rabies antibodies by enzyme-linked immunosorbent assay and its comparative analysis with rapid fluorescent focus inhibition test in mouse …

AD Ashis Debnath, DC Pathak… - 2019 - cabidigitallibrary.org
Aim: In this study, we have used enzyme-linked immunosorbent assay (ELISA) as an
alternative test to replace the cumbersome rapid fluorescent focus inhibition test (RFFIT) to …

[HTML][HTML] Serological profiling of rabies antibodies by enzyme-linked immunosorbent assay and its comparative analysis with rapid fluorescent focus inhibition test in …

A Debnath, DC Pathak, N Ramamurthy, G Mohd… - 2019 - veterinaryworld.org
Aim: In this study, we have used enzyme-linked immunosorbent assay (ELISA) as an
alternative test to replace the cumbersome rapid fluorescent focus inhibition test (RFFIT) to …